Table 3.
Crude model | Model 1 | Model 2 | |||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p value | OR | 95% CI | p value | OR | 95% CI | p value | |
Periodontitis | |||||||||
Stage I | 1.73 | 0.82–3.64 | 0.14 | 1.41 | 0.60–3.30 | 0.42 | 1.41 | 0.60–3.29 | 0.43 |
Stage II | 1.84 | 0.97–3.50 | 0.06 | 1.62 | 0.79–3.29 | 0.18 | 1.62 | 0.79–3.31 | 0.18 |
Stage III | 3.65 | 1.83–7.28 | < 0.001 | 3.19 | 1.42–7.14 | 0.005 | 3.20 | 1.42–7.18 | 0.005 |
p value for trend | < 0.001 | 0.001 | 0.004 | ||||||
Central obesity (waist circumference ≥ 90 cm for men and ≥ 80 cm for women) | 1.82 | 1.17–2.85 | 0.008 | 1.15 | 0.68–1.95 | 0.61 | 1.19 | 0.59–2.39 | 0.63 |
Hypertension (blood pressure ≥ 130/85 mmHg) | 1.50 | 0.96–2.33 | 0.07 | 1.34 | 0.81–2.20 | 0.25 | 1.35 | 0.81–2.23 | 0.25 |
Total cholesterol ≥ 200 mg/dL | 2.12 | 1.35–3.43 | 0.001 | 1.42 | 0.77–2.62 | 0.26 | 1.42 | 0.77–2.61 | 0.26 |
LDL-C > 100 mg/dL | 1.60 | 1.02–2.49 | 0.04 | 1.23 | 0.71–2.12 | 0.46 | 1.23 | 0.71–2.14 | 0.45 |
HDL-C < 40 mg/dL | 1.07 | 0.60–1.89 | 0.83 | 1.00 | 0.53–1.88 | 0.99 | 1.00 | 0.53–1.88 | 0.99 |
Triglycerides ≥ 150 mg/dL | 1.68 | 1.03–2.72 | 0.03 | 1.03 | 0.57–1.86 | 0.92 | 1.04 | 0.57–1.89 | 0.90 |
Fasting glucose ≥ 100 mg/dL | 1.15 | 0.70–1.90 | 0.57 | 0.73 | 0.40–1.32 | 0.29 | 0.73 | 0.40–1.33 | 0.29 |
Hyperuricemia (uric acid ≥ 7.0 mg/dL for men and ≥ 6.0 mg/dL for women) | 1.20 | 0.78–1.86 | 0.40 | 1.26 | 0.79–2.02 | 0.33 | 1.26 | 0.79–2.03 | 0.33 |
Leucocyte counts ≥ 7.6 103/µL | 1.77 | 1.10–2.86 | 0.01 | 1.86 | 1.11–3.10 | 0.01 | 1.86 | 1.11–3.12 | 0.01 |
Data are presented as odds ratios (OR) and 95% confidence intervals (CI) using multiple logistic regression analysis.
Multiple logistic regression model was additionally adjusted with age, sex, tooth brushing frequency, alcohol intake and tobacco smoking in Model 1; BMI was further adjusted in Model 2.
LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol.